| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |